ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Onward Medical NV

Onward Medical NV (ONWD)

4,75
0,00
(0,00%)
Geschlossen 25 November 5:30PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
4,75
Gebot
4,69
Fragen
4,78
Volumen
52.783
4,71 Tagesbereich 4,85
1,85 52-Wochen-Bereich 6,58
Marktkapitalisierung
Handelsende
4,75
Handelsbeginn
4,79
Letzte Trade
1
@
4.75
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
72.330
Ausgegebene Aktien
34.628.832
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,60
Gewinn pro Aktie (EPS)
-1,04
Erlöse
532k
Nettogewinn
-36,18M

Über Onward Medical NV

Sektor
Medical Laboratories
Branche
Medical Laboratories
Website
Hauptsitz
Eindhoven, North Brabant, Nld
Gegründet
-
Onward Medical NV is listed in the Medical Laboratories sector of the Euronext with ticker ONWD. The last closing price for Onward Medical NV was 4,75 €. Over the last year, Onward Medical NV shares have traded in a share price range of 1,85 € to 6,58 €.

Onward Medical NV currently has 34.628.832 shares in issue. The market capitalisation of Onward Medical NV is 164,49 € million. Onward Medical NV has a price to earnings ratio (PE ratio) of -4.60.

ONWD Neueste Nachrichten

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke

Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke...

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke Grant supports the first clinical trials studying the potential for brain-computer interface...

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights Company to provide update on significant milestones and near-term plans, including its recent successful...

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights

EINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to...

ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024

ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024 EINDHOVEN, the Netherlands, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology...

ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024

EINDHOVEN, the Netherlands, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function...

ONWARD® Medical Publishes Closing of Bookbuild Offering

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 28, 2024 (GLOBE NEWSWIRE...

ONWARD® Medical Publishes Closing of Bookbuild Offering

ONWARD® Medical Publishes Closing of Bookbuild Offering THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014...

ONWARD® Medical Publishes Prospectus for Listing of New Shares

ONWARD® Medical Publishes Prospectus for Listing of New Shares THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION...

ONWARD® Medical Publishes Prospectus for Listing of New Shares

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 24, 2024 (GLOBE NEWSWIRE...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1-2.06185567014.854.884.51666194.69618737DE
4-0.15-3.06122448984.95.264.51644844.90551039DE
12004.756.34.51723305.11663148DE
26-0.49-9.351145038175.246.34.51465025.0985307DE
521.1531.94444444443.66.581.85679804.9941036DE
156-6.51-57.815275310811.2612.281.85279925.15346209DE
260-8.27-63.517665130613.0213.281.85284215.50082292DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ATOAtos SE
0,3102 €
(98,85%)
29,05M
ALIMOGroupimo
0,276 €
(46,03%)
100
ALROCRoctool
0,36 €
(23,29%)
306,32k
ALARFAdeunis
0,782 €
(20,68%)
3,34k
SOISOITEC
84,75 €
(15,78%)
476,44k
EMGDSEuromedis DS
0,0006 €
(-93,33%)
199,36k
BIDSGascogne DS
0,0024 €
(-52,00%)
75,95k
ALCHIAlchimie
0,266 €
(-16,09%)
71,82k
ALDOLDolfines
1,95 €
(-15,22%)
23,68k
ALICRICeram
0,402 €
(-12,61%)
493
BCPBanco Comercial Portugues SA
0,4471 €
(0,56%)
137,15M
EDPEDP SA
3,515 €
(0,98%)
38,88M
ALNEVNeovacs
0,0002 €
(0,00%)
33,1M
ATOAtos SE
0,3102 €
(98,85%)
29,05M
KPNKoninklijke KPN NV
3,65 €
(0,83%)
21,8M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock